SK to strengthen technical ties with Chinese company

Published: 2011-10-18 06:56:00

Updated: 2011-10-18 06:56:00

SK Biopharmaceuticals Co., which was established in April as a subsidiary of the SK Group’s holdings company SK Corp., said Sunday that it has signed a licensing agreement with a Chinese drug firm to develop and market a potential treatment for depression and bipolar disorder.

Under the terms of the agreement, SK Biopharmaceuticals will work with Shanghai Medicilon to complete preclinical t...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.